Why are physicians so skeptical about positive randomized controlled clinical trials in critical care medicine?

Intensive Care Medicine

Volumn 31, Issue 2, 2005, Pages 196-204

  Villar, Jesús ^a,b,c   Pérez Méndez, Lina ^a,c   Aguirre Jaime, Armando ^a   Kacmarek, Robert M ^d,e  

^a HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c CSIC   (Spain)

^d HARVARD MEDICAL SCHOOL   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; STREPTOMYCIN;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTIFICIAL VENTILATION; BLEEDING; CLINICAL TRIAL; CONSENSUS; DRUG EFFICACY; DRUG SAFETY; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; LUNG TUBERCULOSIS; MEDICAL PRACTICE; MORTALITY; NOTE; PHYSICIAN; RESPIRATORY FAILURE; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK REDUCTION; SEPSIS; SIDE EFFECT; STATISTICAL SIGNIFICANCE; TIDAL VOLUME; TREATMENT OUTCOME;

ATTITUDE OF HEALTH PERSONNEL; CRITICAL CARE; DIFFUSION OF INNOVATION; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT SELECTION; PHYSICIANS; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN;

EID: 14944386456     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-004-2519-7     Document Type: Note

References (40)

1. Brochard L, Mancebo J, Tobin M (2003) Searching for evidence: don't forget the foundations. Intensive Care Med 29:2109-1111
2. Buckley NA, Smith AJ (1996) Evidence-based medicine in toxicology: where is the evidence? Lancet 347:1167-1169
3. Simes RJ (2002) Clinical trials and "real-world" medicine. Med J Aust 177:407-408
4. Acute Respiratory Distress Syndrome Network (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342:1301-1308
5. Bernard GR, Vincent JL, Laterre PF, La Rosa SP, Dhainaut JF, López-Rodríguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fischer CJ Jr (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:699-709
6. Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E (1999) A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 340:409-417
7. Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troche G, Chaumet-Riffaut P, Bellissant E (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288:862-871
8. Rubenfeld GD, Cooper C, Carter G, Thompson BT, Hudson LD (2004) Barriers to providing lung-protective ventilation to patients with acute lung injury. Crit Care Med 32:1289-1293
9. Kalassian KG, Dremsizov T, Angus DC (2002) Translating research evidence into clinical practice: new challenges for critical care. Crit Care 6:11-14
10. Taubes G (1996) Looking for the evidence in medicine. Science 272:22-24
11. Davis D, O'Brien MA, Freemantle N, Wolf FM, Mazmanian P, Taylor-Vaisey A (1999) Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behaviour or health care outcomes? JAMA 282:867-874
12. Marshall BJ, Warren JR (1984) Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet I:1311-1315
13. Weinert CR, Gross CR, Marinelli WA (2003) Impact of randomized trial results on acute lung injury ventilator therapy in teaching hospitals. Am J Respir Crit Care Med 167:1304-1309
14. Villar J, Kacmarek RM, Hedenstierna G (2004) From ventilator-induced lung injury to physician-induced lung injury: why the reluctance to use small tidal volumes? Acta Anaesthesiol Scand 48:267-271
15. Eichacker PQ, Gerstenberger EP, Banks SM, Cui X, Natanson C (2002) Meta-analysis of acute lung injury and acute respiratory distress syndrome trials testing low tidal volumes. Am J Respir Crit Care Med 166:1510-1514
16. Steinbrook R (2003) How best to ventilate? Trial design and patient safety in studies of the acute respiratory distress syndrome. N Engl J Med 348:1393-1401
17. Thompson B, Hayden D, Matthay MA, Brower R, Parson P (2001) Clinicians' approach to mechanical ventilation in acute lung injury and ARDS. Chest 120:1622-1627
18. Hayden D, Schoenfeld D, Bernard G, Brower R (2000) Outcome of participants vs. eligible participants in clinical trial of critically ill patients (abstract). Am J Respir Crit Care Med 161:A210
19. Villar J, Pérez-Méndez L, Kacmarek RM (1999) Current definitions of acute lung injury and the acute respiratory distress syndrome do not reflect their true severity and outcome. Intensive Care Med 25:930-935
20. Ferguson ND, Kacmarek RM, Chiche JD, Singh JM, Hallett DC, Mehta S, Stewart TE (2004) Screening of ARDS patients using standardized ventilator settings: influence on enrolment in a clinical trial. Intensive Care Med 30:1111-1116
21. Freeman BD, Danner RL, Banks SM, Natanson C (2001) Safeguarding patients in clinical trials with high mortality rates. Am J Respir Crit Care Med 164:190-192
22. Horrobin DF (2003) Are large clinical trials in rapidly lethal diseases usually unethical? Lancet 361:695-697
23. Petrucci N (2003) Generalisability of randomised controlled trials: a matter of discussion. Intensive Care Med 29:858
24. Pronovost PJ, Berenholtz SM, Dorman T, Merritt WT, Martinez EA, Guyatt GH (2001) Evidence-based medicine in anesthesiology. Anesth Analg 92:787-794
25. MRC Streptomycin in Tuberculosis Trials Committee (1948) Streptomycin treatment of pulmonary tuberculosis. BMJ II:769-783
26. Hart PD (1999) A change in scientific approach: from alternation to randomised allocation in clinical trials in the 1940s. BMJ 319:572-573
27. Altman DG (1998) Confidence intervals for the number needed to treat. BMJ 317:1309-1312
28. Roupie E, Lepage E, Wysocki M, Fagon JY, Chastre J, Dreyfuss D, Mentec H, Carlet J, Brun-Buisson C, Lemaire F, Brochard L (1999) Prevalence, etiologies and outcome of the acute respiratory distress syndrome among hypoxemic ventilated patients. Intensive Care Med 25:920-929
29. Brun-Buisson C, Minelli C, Bertolini G, Brazzi L, Pimentel J, Lewandowski K, Bion J, Romand JA, Villar J, Thorsteinsson A, Damas P, Armaganidis A, Lemaire F (2004) Epidemiology and outcome of acute lung injury in European intensive care units. Results from the ALIVE study. Intensive Care Med 30:51-61
30. Hebert PC, Wells G, Martin C, Tweeddale M, Marshall J, Blajchman M, Pagliarello G, Sandham D, Schweitzer II, Boisvert D, Calder L (1999) Variation in red cell transfusion practice in the intensive care unit: a multicentre cohort study. Crit Care 3:57-63
31. Boraless H, Rao MP, Morgan C, Soni N, Goldhill DR, Brett SJ, Boralessi H, Contreras M (2002) A survey of physicians' attitudes to transfusion practice in critically ill patients in the UK. Anaesthesia 57:584-588
32. Hotchkiss RS, Karl IE (2003) The pathophysiology and treatment of sepsis. N Engl J Med 348:138-150
33. Warren HS, Suffredini AF, Eichacker PQ, Munford RS (2002) Risks and benefits of activated protein C treatment for severe sepsis. N Engl J Med 347:1027-1030
34. Ross SS (2004) From p values to Bayesian statistics, it's all in the numbers. Scientist 18:24-25
35. Heyland DK, MacDonald S, Keefe L, Drover JW (1998) Total parenteral nutrition in the critically ill patient: a meta-analysis. JAMA 280:2013-2019
36. Sadowski ZP, Alexander JH, Skrabucha B, Dyduszynski A, Kuch J, Nartowicz E, Swiatecka G, Kong DF, Granger CB (1999) Multicenter randomized trial and systematic overview of lidocaine in acute myocardial infarction. Am Heart J 137:792-798
37. Lexchin J, Bero LA, Djulbegovic B, Clark O (2003) Pharmaceutical industry sponsorship and research outcome and quality: systemic review. BMJ 326:1167-1170
38. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study (1995) Endarterectomy for asymptomatic carotid artery stenosis. JAMA 273:1421-1428
39. Wennberg DE, Lucas FL, Birkmeyer JD, Bredenberg CE, Fisher ES (1998) Variation in carotid endarterectomy mortality in the Medicare population. JAMA 279:1278-1281
40. Holmberg L, Baum M (1995) Can results from clinical trials be generalized? Nat Med 1:734-736